Results 1 to 10 of about 42,137 (194)
Niacin, as an antidyslipidemic drug, elicits a strong flushing response by release of prostaglandin (PG) D2. However, whether niacin is beneficial for inflammatory bowel disease (IBD) remains unclear. Here, we observed niacin administration‐enhanced PGD2
Lifu Wang +2 more
exaly +2 more sources
The widely used lipid-lowering drug niacin was reported to increase blood glucose in diabetes. How does niacin regulate β Cell function in diabetic patients remains unclear.
Xiaojing Zhang +9 more
doaj +1 more source
Previous experimental models on cows have examined the difference in the metabolic adaptation in cows after niacin administration, without identifying the most important mediators between niacin administration and its biological effects, namely active ...
Kosta Petrović +11 more
doaj +1 more source
A 60-day feeding trial was conducted to determine the effects of the interaction of dietary niacin and lipid on the growth, antioxidant capacity and lipid metabolism in male Eriocheir sinensis.
Wenlong Wan +6 more
doaj +1 more source
Niacin – a scoping review for Nordic Nutrition Recommendations 2023
Niacin is the precursor to pyridine nucleotides NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate). Niacin (vitamin B3) is the common term for nicotinic acid, nicotinamide and derivatives that exhibit the ...
Riitta Freese, Vegard Lysne
doaj +1 more source
Dietary Niacin Supplementation Suppressed Hepatic Lipid Accumulation in Rabbits [PDF]
An experiment was conducted to investigate the effect of niacin supplementation on hepatic lipid metabolism in rabbits. Rex Rabbits (90 d, n = 32) were allocated to two equal treatment groups: Fed basal diet (control) or fed basal diet with additional ...
Lei Liu +3 more
doaj +1 more source
Structural and Energetic Insights Into the Interaction of Niacin With the GPR109A Receptor
The transmembrane G-protein coupled receptor GPR109A has been previously shown to function as a receptor for niacin in mediating antilipolytic effects.
Kiran Kumar Adepu +3 more
doaj +1 more source
Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells1
Niacin is a widely used lipid-regulating agent in dyslipidemic patients. Previously, we have shown that niacin inhibits triacylglycerol synthesis.
Shobha H. Ganji +5 more
doaj +1 more source
Background The vitamin niacin is used as a lipid-regulating supplement, but it is unknown whether niacin has a positive influence on cancer prognosis.
Hongan Ying +5 more
doaj +1 more source
A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson’s disease (PD) patients.
Chandramohan Wakade +5 more
doaj +1 more source

